During the past decade, Denver Nephrologists, PC conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 11 clinical trials were completed, i.e. on average, 64.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Denver Nephrologists, PC" #1 sponsor was "Denver Nephrologists, P.C." with 7 trials, followed by "La Jolla Pharmaceutical Company" with 5 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Goldfinch Bio, Inc." with 3 trials sponsored and "Reata Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Denver Nephrologists, PC" #1 collaborator was "CM&D Pharma Limited" with 4 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Baim Institute for Clinical Research" with 1 trials as a collaborator, "CM&D Pharma, LTD" with 1 trials as a collaborator and "DaVita Dialysis" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Denver Nephrologists, PC" are "Chronic Kidney Disease" (12 trials), "Hyperphosphatemia" (3 trials), "Chronic Kidney Diseases" (2 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Diabetic Nephropathies" (2 trials). Many other conditions were trialed in "Denver Nephrologists, PC" in a lesser frequency.

Most popular intervention types in "Denver Nephrologists, PC" are "Drug" (28 trials), "Other" (6 trials), "Biological" (3 trials), "Device" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "GCS-100" (5 trials), "Placebo" (5 trials), "Belatacept" (2 trials), "GFB-887" (2 trials) and "Lanthanum Carbonate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Denver Nephrologists, PC" are 39 trials for "All" genders.

Currently, there are NaN active trials in "Denver Nephrologists, PC". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Denver Nephrologists, PC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Denver Nephrologists, PC, 2 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".